Literature DB >> 18775420

Role of sex and time of blood sampling in SOD1 and SOD2 expression variability.

Olha Khymenets1, Maria Isabel Covas, Magi Farré, Klaus Langohr, Montserrat Fitó, Rafael de la Torre.   

Abstract

OBJECTIVES: This study investigates how some of human physiological parameters, in particular sex and daytime, can contribute to the normal variation in blood gene expression. DESIGN AND METHODS: The expressions of two genes: SOD1 (Cu/Zn) and SOD2 (Mn) in white blood cells of 19 healthy individuals (10 men and 9 women) were examined by qPCR at 09.00, 12.00, and 15.00 h over three consecutive weeks at 7-day intervals. SOD1 and SOD2 expressions differ between sexes, higher expression being exhibited in males (P<0.005). In the male group both genes had lower expression (P<0.005) with smaller variation at 09.00 h. In females, both inter- and intra-subject, variability in SOD1 expression was increased at ovulation. Intra-individually, the expressions of genes positively correlated in males, but less in females.
CONCLUSIONS: SOD1 and SOD2 expressions demonstrate how sex and daytime, merit being controlled when human gene expression analyses are evaluated, particularly within the framework of clinical trials or cohort studies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18775420     DOI: 10.1016/j.clinbiochem.2008.08.064

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  2 in total

1.  Multiple testing for gene sets from microarray experiments.

Authors:  Insuk Sohn; Kouros Owzar; Johan Lim; Stephen L George; Stephanie Mackey Cushman; Sin-Ho Jung
Journal:  BMC Bioinformatics       Date:  2011-05-26       Impact factor: 3.169

2.  Validation and characterization of DNA microarray gene expression data distribution and associated moments.

Authors:  Reuben Thomas; Luis de la Torre; Xiaoqing Chang; Sanjay Mehrotra
Journal:  BMC Bioinformatics       Date:  2010-11-24       Impact factor: 3.169

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.